Financial Data
Note: This is a “non-consolidated” result that does not include the group company in US and China.
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Sales | 5,468 |
6,317 |
8,265 |
9,859 |
9,877 |
| Net Income | △62 |
165 |
503 |
378 |
68 |
| Net Income Ratio (%) | △1.1 |
2.6 |
6.1 |
3.8 |
0.7 |
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Total Assets | 7,161 |
8,453 |
10,665 |
11,483 |
12,343 |
| Equity | 2,859 |
3,050 |
3,625 |
4,028 |
4,094 |
| Equity Ratio (%) | 39.9 |
36.0 |
34.0 |
35.1 |
33.2 |
The disclosed figures are from the non-consolidated financial statements audited by Deloitte Touche Tohmatsu LLC under the Japanese Companies Act. From 2022, the “Accounting Standard for Revenue Recognition” (ASBJ Statement No. 29, March 31st, 2020) has been applied to our sales. The figures of wholly owned subsidiary companies in China and US are not included.
